|

TP or PF regimen depended on investigator's choice. Clinical Trials

1 actively recruiting trial

Also known as: Chemotherapy

Pipeline

Phase 3: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Esophageal Neoplasms1
  • Cancer1

Other1 trial

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.